Davita DVA

  1. All
  2. Commentary
  3. Stock Reports
  4. Video Reports
  5. Fund Reports
  6. Headlines
    1. Tracking Warren Buffett's Berkshire Hathaway Portfolio - Q2 2014 Update


      Sat, 16 Aug 2014

      By John Vincent : This article is part of a series that provides an ongoing analysis of the changes made to Berkshire Hathaway's US stock portfolio on a quarterly basis. It is based on Warren Buffett's regulatory 13F Form filed on 08/14/2014. Please visit our Tracking 10 Years Of Berkshire ...

    2. Update: NxStage Medical Earnings


      Wed, 13 Aug 2014

      its previous guidance of $283 to $288 million. Although established players like Fresenius (NYSE: FMS ) and DaVita (NYSE: DVA ) account for more than half of the conventional dialysis market segment in the US, NxStage Medical's System

    3. New Morningstar Analyst Report for DaVita HealthCare Partners Inc

      Stock Reports

      Tue, 12 Aug 2014

      DaVita 's profitability is largely dependent on ..... paying exchange plans could adversely affect DaVita 's bottom line.Federal government changes ..... Amgen's Epogen could eventually improve DaVita 's profitability. Management has historically

    4. Update: DaVita Is Still Undervalued, Despite Headwinds


      Mon, 4 Aug 2014

      By Early Retiree : On July 31 DaVita (NYSE: DVA ) delivered a mixed bag of results ..... These issues prompted Kent Thiry, DaVita 's CEO, to step in personally ..... business will continue to do well. DaVita now expects 2014 consolidated operating

    5. Kidney Care Remains DaVita ’s Bright Spot in a Tough Environment


      Fri, 1 Aug 2014

      Despite weakness in both of DaVita HealthCare Partners’ business segments, the ..... reduction in administrative costs, DaVita upheld healthy segment operating margin ..... treatment growth to remain strong for DaVita . We also expect profitability to improve

    6. DaVita HealthCare Partners' ( DVA ) CEO Kent Thiry on Q2 2014 Results - Earnings Call Transcript


      Thu, 31 Jul 2014

      DaVita HealthCare Partners (NYSE: DVA ) Q2 2014 Earnings Call July 31, 2014 5:00 pm ET Executives ..... coordinator today. At this time, I would like to welcome everyone to DaVita HealthCare Partners Second Quarter 2014 Earnings Call. [Operator

    7. DaVita updated guidance after Q2 results


      Thu, 31 Jul 2014

      DaVita HealthCare Partners ( DVA -1.2% ) Q2 results : Total Net Revenues: $3,172.5M (+10.5%); Operating Expenses: $2,688.2M (+14.4

    8. Fresenius Meets Expectations and Cautiously Enters Coordinated-Care Market


      Thu, 31 Jul 2014

      Illinois and Texas. We're usually skeptical of deals outside of management's expertise in dialysis, a criticism we share with DaVita 's large merger with Healthcare Partners. While we think Fresenius' global dominance in the dialysis market is enough to

    9. DaVita chief resigns effective August 1


      Mon, 21 Jul 2014

      Shares of DaVita HealthCare Partners ( DVA -3.7% ) are down on modestly higher volume after the company announced that CEO Dr. Craig Samitt is quitting on August 1

    10. Morgan Stanley +2.2% after sizable earnings beat


      Thu, 17 Jul 2014

      Excluding DVA , income of $1.9B or $0.91 per share vs. $900M and $0.37 one year ..... 927M vs. $806M one year ago on roughly flat revenue of $4.16B (excl. DVA ). FICC revenue of $1B slips from $1.2B, partially offset by higher

    « Prev12345Next »
    Content Partners